| 1 |
32166540 | Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban. | 2020 Aug |
2 |
| 2 |
27796530 | Assessment of trough rivaroxaban concentrations on markers of coagulation activation in nonvalvular atrial fibrillation population. | 2017 May |
1 |
| 3 |
28735423 | The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban. | 2017 Sep |
1 |
| 4 |
26644369 | Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects. | 2016 Feb |
1 |